Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Recommendations

[1]  K. Salmenkivi,et al.  Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined Immunosuppression , 2013, Circulation. Heart failure.

[2]  Robert A. deKemp,et al.  The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience , 2012, The Journal of Nuclear Medicine.

[3]  M. Abrar,et al.  Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake , 2011, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[4]  M. Kupari,et al.  Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged Adults , 2011, Circulation. Arrhythmia and electrophysiology.

[5]  H. Ohira,et al.  18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  M. Nishimura,et al.  Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography. , 2011, Internal medicine.

[7]  T. Imaizumi,et al.  Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. , 2010, JACC. Cardiovascular imaging.

[8]  D. Berman,et al.  Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[9]  W. Oyen,et al.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  A. Burke,et al.  Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. , 2009, The American journal of cardiology.

[11]  M. Gebregziabher,et al.  Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[12]  J. Wykrzykowska,et al.  Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation , 2009, Journal of Nuclear Medicine.

[13]  G. Kolodny,et al.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. , 2008, AJR. American journal of roentgenology.

[14]  M. Nishimura,et al.  Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  H. Morita,et al.  Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. , 2007, Heart rhythm.

[16]  Stephen L. Bacharach,et al.  Positron emission tomography myocardial perfusion and glucose metabolism imaging , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[17]  Marc Kachelriess,et al.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  P. Wells,et al.  Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. , 2005, Blood.

[19]  Sibylle Ziegler,et al.  PET/CT: challenge for nuclear cardiology. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  M. Nishimura,et al.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. , 2005, European heart journal.

[21]  I. Jang,et al.  When heparins promote thrombosis: review of heparin-induced thrombocytopenia. , 2005, Circulation.

[22]  P. Herrero,et al.  Imaging of myocardial metabolism , 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[23]  T. Yokoyama,et al.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  K. Frayn.  The glucose-fatty acid cycle: a physiological perspective. , 2003, Biochemical Society transactions.

[25]  M. Yoshiyama,et al.  Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  M. Coel,et al.  Reduction of myocardial 2-deoxy-2-[18F]fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[27]  T. Nakata,et al.  Technetium-99m Sestamibi/Tetrofosmin Myocardial Perfusion Scanning in Cardiac and Noncardiac Sarcoidosis , 2001, Cardiology.

[28]  M. Hays,et al.  A mathematical model for the distribution of fluorodeoxyglucose in humans. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  S L Bacharach,et al.  Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  A. Movahed,et al.  Sarcoidosis of the Heart , 1993, Clinical cardiology.

[31]  U Ruotsalainen,et al.  Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. , 1992, The Journal of clinical investigation.

[32]  F. Fazio,et al.  Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[34]  The japanese society of nuclear medicine , 1990 .

[35]  R. Gropler,et al.  Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  H. Ehmke,et al.  Influence of the renin-angiotensin system on the autoregulation of renal blood flow and glomerular filtration rate in conscious dogs. , 1988, Acta physiologica Scandinavica.

[37]  A. Nitenberg,et al.  Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. , 1988, The American journal of medicine.

[38]  E. Persson.  Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin). , 1988, Acta medica Scandinavica. Supplementum.

[39]  M. Mayr,et al.  Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. , 1987, The Journal of clinical investigation.

[40]  W. Roberts,et al.  Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II) , 1977 .